Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRLH | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
mRNA | ITGB1 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | ZHX3 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | APAF1 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | YIPF2 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
mRNA | PRR16 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | TEX10 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | RMND5A | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | UBE2T | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | ZNF207 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |